INFANTILE CORTICAL HYPEROSTOSIS

This adverse event was reported 22 times

INFANTILE CORTICAL HYPEROSTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostaglandin Analog [EPC] 12 0.0001
1 Orexin Receptor Antagonist [EPC] 2 0.0001
2 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
3 Glycopeptide Antibacterial [EPC] 1 0.0000
4 Aldosterone Antagonist [EPC] 1 0.0000
5 Opioid Agonist [EPC] 1 0.0000
6 Loop Diuretic [EPC] 1 0.0000
7 Benzodiazepine [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with INFANTILE CORTICAL HYPEROSTOSIS